Comment on

• Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10).

  Hervé P, Wijdenes J, Bergerat JP, Bordigoni P, Milpied N, Cahn JY, Clément C, Béliard R, Morel-Fourrier B, Racadot E, et al. Hervé P, et al. Blood. 1990 Feb 15;75(4):1017-23. Blood. 1990. PMID: 2136244 Clinical Trial.
• Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

  Holler E, Kolb HJ, Möller A, Kempeni J, Liesenfeld S, Pechumer H, Lehmacher W, Ruckdeschel G, Gleixner B, Riedner C, et al. Holler E, et al. Blood. 1990 Feb 15;75(4):1011-6. Blood. 1990. PMID: 2405918